Skip to main content

Wingstop Inc

For the period ended Mar 29, 2025. Filed Apr 30, 2025.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Mar 29, 2025 · Filed Apr 30, 2025

WING$169.58-4.2%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Consolidated Statements of Cash Flows (Unaudited) - Thirteen Weeks Ended

Consolidated Statements of Cash Flows

(amounts in thousands)

Thirteen Weeks Ended
March 29,2025March 30,2024
Operating activities
Net income$92,265$28,747
Adjustments to reconcile net income to cash provided by operating activities:
Depreciation and amortization6,2283,410
Deferred income taxes13,3201,913
Stock-based compensation expense5,3123,812
Loss on disposal of assets6,535—
Gain on sale of investment(92,485)—
Amortization of debt issuance costs769516
Changes in operating assets and liabilities:
Accounts receivable1,209(1,235)
Prepaid expenses and other assets(8,269)391
Advertising fund assets and liabilities, net(15,223)5,297
Accounts payable and other current liabilities12,223(127)
Deferred revenue2,5151,922
Other non-current liabilities89513
Cash provided by operating activities25,29444,659
Investing activities
Purchases of property and equipment(8,022)(11,158)
Proceeds from sales of assets17,330—
Payments for investments(76,513)(500)
Proceeds from sale of investments107,700—
Cash (used in) provided by investing activities40,495(11,658)
Financing activities
Proceeds from exercise of stock options—708
Purchases of common stock(120,772)—
Tax payments for restricted stock upon vesting(11,597)(3,717)
Dividends paid(8,046)(6,606)
Cash used in financing activities(140,415)(9,615)
Net increase in cash, cash equivalents, and restricted cash(74,626)23,386
Cash, cash equivalents, and restricted cash at beginning of period359,574119,676
Cash, cash equivalents, and restricted cash at end of period$284,948$143,062
Supplemental information:
Accrued capital expenditures$6,689$2,531
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.